04.08.2014 • TopicsREAChReach complianceSusanne Kamptmann

REACH Compliance

REACH Compliance  The Great Challenge for Globally Acting Enterprises
REACH Compliance The Great Challenge for Globally Acting Enterprises

REACH Compliance: The Great Challenge for Globally Acting Enterprises is the only book to not only discuss the technicalities of the European REACH chemicals registration process, but also to directly address the resulting business risks and business solutions.

In this text for practitioners, the author pulls together the key knowledge needed to successfully run a business under REACH, distilling thousands of pages of official documentation, and incorporating experiences from different-sized enterprises in a global context.Starting with the basics of the REACH framework, the author explains the entire process on how to register with the European ECHA office with a particular emphasis on small and medium-sized businesses.

Along the way, she describes key milestones and presents sample documents from real case studies. The final part of the book addresses strategies to ensure a reach-compliant operation, including recommendations for in-house processes as well as communicating with suppliers and downstream users.

REACH Compliance
Susanne Kamptmann
Wiley-VCH
Price: € 89,00
ISBN 13: 978-3-527-33316-5

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.